Inozyme Pharma Inc. (INZY)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

2.99

-0.83%

After-hours Dec 13, 2024, 04:10 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Revenue	-	-	-	-	-	-
Cost of Revenue	1.29M	1.18M	1.05M	217.00K	83.00K	26.00K
Gross Profit	-1.29M	-1.18M	-1.05M	-217.00K	-83.00K	-26.00K
Operating Income	-75.64M	-68.67M	-56.65M	-57.04M	-20.81M	-11.59M
Interest Income	7.84M	1.93M	211.00K	370.00K	1.11M	284.00K
Pretax Income	-71.17M	-67.06M	-56.62M	-56.42M	-19.72M	-6.96M
Net Income	-71.17M	-65.45M	-56.41M	-55.84M	-18.62M	-6.96M
Selling & General & Admin	20.80M	20.83M	18.93M	10.55M	4.59M	3.49M
Research & Development	54.85M	47.85M	37.72M	46.49M	16.22M	8.10M
Other Expenses	-	-319.00K	-189.00K	247.00K	-24.00K	4.34M
Operating Expenses	75.64M	68.67M	56.65M	57.04M	20.81M	11.59M
Interest Expense	3.33M	-	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-
Cost & Expenses	75.64M	68.67M	56.65M	57.04M	20.81M	11.59M
Income Tax	-	-1.61M	-211.00K	-587.00K	-1.11M	4.63M
Shares Outstanding (Basic)	51.84M	37.76M	23.56M	23.38M	15.16M	15.14M
Shares Outstanding (Diluted)	51.84M	37.76M	23.56M	23.38M	15.16M	15.14M
EPS (Basic)	-1.37	-1.73	-2.39	-2.39	-1.23	-0.46
EPS (Diluted)	-1.37	-1.73	-2.39	-2.39	-1.23	-0.46
EBITDA	-74.81M	-65.88M	-55.97M	-56.82M	-20.72M	-11.57M
Depreciation & Amortization	833.00K	1.18M	1.05M	217.00K	83.00K	26.00K